menu
    • menu

    Company profile for Cyclacel Pharmaceuticals

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cyclacel is a clinical-stage biopharmaceutical company using cell cycle control, transcriptional regulation and DNA damage response biology to develop innovative, targeted medicines for cancer and other proliferative diseases. Cyclacel's founding scientist, Professor Sir David Lane, is a globally recognized authority in cell cycle biology, who discovered p53, a key tumor suppressor gene that malfunctions in about two-thirds of...
    Cyclacel is a clinical-stage biopharmaceutical company using cell cycle control, transcriptional regulation and DNA damage response biology to develop innovative, targeted medicines for cancer and other proliferative diseases. Cyclacel's founding scientist, Professor Sir David Lane, is a globally recognized authority in cell cycle biology, who discovered p53, a key tumor suppressor gene that malfunctions in about two-thirds of human cancers. Under his guidance, Cyclacel's drug discovery and development programs concentrated on the CDK2/9 isoforms, which operate as key components of the p53 pathway.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cyclacel PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    200 Connell Drive #1500 Berkeley Heights, NJ 07922
    Telephone
    Telephone
    +1 (908) 517 7330
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://cyclacel.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bio Green Med Solution Reports Q3 Financial Results And Business
    Bio Green Med Solution Reports Q3 Financial Results And Business

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187901/10564/en/Bio-Green-Med-Solution-Reports-Third-Quarter-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    Bio Green Med Solution Closes Acquisition of Fitters Sdn. Bhd.
    Bio Green Med Solution Closes Acquisition of Fitters Sdn. Bhd.

    12 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/12/3149093/10564/en/Bio-Green-Med-Solution-Inc-Announces-Closing-of-Strategic-Acquisition-of-Fitters-Sdn-Bhd.html

    GLOBENEWSWIRE
    12 Sep 2025
    Share Share
    Cyclacel Pharma Q2 2025 Financial Results and Business Update
    Cyclacel Pharma Q2 2025 Financial Results and Business Update

    13 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/13/3132966/10564/en/Cyclacel-Pharmaceuticals-Reports-Second-Quarter-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    13 Aug 2025
    Share Share
    Cyclacel Pharmaceuticals: Preclinical data show Plogosertib
    Cyclacel Pharmaceuticals: Preclinical data show Plogosertib

    04 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/04/3126990/0/en/CYCLACEL-PHARMACEUTICALS-HIGHLIGHTS-PRECLINICAL-DATA-SHOWING-THAT-CANCER-OF-THE-BILIARY-TRACT-IS-SENSITIVE-TO-PLOGOSERTIB.html

    GLOBENEWSWIRE
    04 Aug 2025
    Share Share
    Cyclacel Pharma Discusses Recent Stock Price Fluctuations
    Cyclacel Pharma Discusses Recent Stock Price Fluctuations

    16 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/16/3116470/0/en/CYCLACEL-PHARMACEUTICALS-COMMENTS-ON-RECENT-STOCK-PRICE-VOLATILITY.html

    GLOBENEWSWIRE
    16 Jul 2025
    Share Share
    Cyclacel Pharmaceuticals Amends Exchange Agreement
    Cyclacel Pharmaceuticals Amends Exchange Agreement

    07 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/07/3110861/0/en/CYCLACEL-PHARMACEUTICALS-ANNOUNCES-AMENDMENT-TO-EXCHANGE-AGREEMENT.html

    GLOBENEWSWIRE
    07 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Contact Cyclacel Pharmaceuticals and get a quotation

    Cyclacel Pharmaceuticals is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of Sapacitabine bulk offered by Cyclacel Pharmaceuticals

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search